Leaflet NATRIXAM 1.5mg / 5mg modified release tablets


Indicated for: hypertension

Substance: indapamide + amlodipine (diuretic + calcium channel blocker)

ATC: C08GA02 (Cardiovascular system | Calcium channel blockers and diuretics)

The combination of indapamide and amlodipine is used for the treatment of hypertension. Indapamide is a thiazide diuretic that reduces blood volume, and amlodipine is a calcium channel blocker that relaxes blood vessels.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to keep blood pressure under control.

Side effects may include dizziness, headache, peripheral edema, or nausea. In rare cases, severe allergic reactions or marked hypotension may occur.

This combination is not recommended for patients with hypersensitivity to any of the components or severe renal impairment.

General data about NATRIXAM 1.5mg / 5mg

  • Substance: indapamide + amlodipine
  • Date of last drug list: 01-07-2014
  • Commercial code: W60529001
  • Concentration: 1.5mg / 5mg
  • Pharmaceutical form: modified release tablets
  • Quantity: 15
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: LES LABORATOIRES SERVIER INDUSTRIE - FRANTA
  • Holder: LES LABORATOIRES SERVIER - FRANTA
  • Number: 13490/2020/01
  • Shelf life: 18 months

Concentrations available for indapamide + amlodipine

  • 1.5mg/10mg
  • 1.5mg/5mg

Combinations with other substances